|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 | |
| G01N 33/574 |
| (11) | Patento numeris | 3444363 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18197141.7 |
| Europos patento paraiškos padavimo data | 2012-05-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161493294 P | 2011-06-03 | US |
| (72) |
Funahashi, Yasuhiro, JP
Kadowaki, Tadashi, JP
Matsui, Junji, JP
Simon, Jason S., US
XU, Lucy, US
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10 Koishikawa, 4-Chome Bunkyo-Ku, Tokyo 112-8088,
JP
|
| (54) | BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |
| BIOMARKERS FOR PREDICITING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS |